{"DataElement":{"publicId":"2182918","version":"2","preferredName":"Eligibility Criteria Indicator","preferredDefinition":"The identifier that indicates whether the participant satisfies the eligibility criteria.","longName":"ELIG_CRIT_IND","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2012997","version":"3","preferredName":"Eligibility Criteria Indicator","preferredDefinition":"Indicator to signify that a subject does or does not meet an eligibility criteria.","longName":"ELIG_CRIT_IND","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2960766","version":"1","preferredName":"Clinical Trial Eligibility Determination","preferredDefinition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, and preventive care.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C71104:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"787DDB80-5FEA-2BA7-E040-BB89AD437EE6","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"ONEDATA","dateModified":"2009-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2415348","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E5B8-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-10-10","modifiedBy":"ONEDATA","dateModified":"2005-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A73E196A-6115-494E-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018691","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"Text terms to determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"YES_NO_U_IND","context":"SPOREs","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B7A8FC01-0A75-33A0-E034-0003BA12F5E7","beginDate":"2002-08-22","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B7A8FC01-0A77-33A0-E034-0003BA12F5E7","beginDate":"2002-08-22","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B7A8FC01-0A79-33A0-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7A8F6CB-D255-3397-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-02-27","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-27","modifiedBy":"REEVESD","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812277","version":"1","longName":"Aminolevulinic Acid - Barrett's Esophagus","context":"DCP"},{"publicId":"2812194","version":"1","longName":"ALA PDT - Oral Leukoplakia","context":"DCP"},{"publicId":"2812190","version":"1","longName":"Acolbifene - High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812177","version":"1","longName":"Safety Study of Resiquimod for Atyical Nevi","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812189","version":"1","longName":"Polyphenon E - Pre-prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"},{"publicId":"2812197","version":"1","longName":"Phase II Resiquimod - Atypical Nevi","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812188","version":"1","longName":"Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men","context":"DCP"},{"publicId":"2812152","version":"1","longName":"Barretts Esophagus - ASA-Esomeprazole","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812102","version":"1","longName":"Budesonide Lung Nodules","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812258","version":"1","longName":"Drug and Carcinogen Enzymes - Resveratrol","context":"DCP"},{"publicId":"2812768","version":"1","longName":"PK and Safety - Novel Retinoid (9cUAB30)","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812843","version":"1","longName":"Polyethylene Glycol - Colon Carcinogenesis","context":"DCP"},{"publicId":"2812836","version":"1","longName":"Imiquimod for Atypical Nevi","context":"DCP"},{"publicId":"2812949","version":"1","longName":"Exp. PK Formulations of SR13668","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2812735","version":"1","longName":"3, 3-Diindolylmethane Cervical Intraepithelial","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2813043","version":"1","longName":"Ursodeoxycholic Acid - Barrett's Patients","context":"DCP"},{"publicId":"2859628","version":"1","longName":"Breast Sulindac DFMO","context":"DCP"},{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"2813002","version":"1","longName":"Sulindac - Increased Risk of Melanoma","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"}]},{"publicId":"2487057","version":"1","longName":"DCP Enterprise System Knowledgebase ","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812178","version":"1","longName":"E-Progress Report","context":"DCP"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776734","version":"1","longName":"All Generic CRFs","context":"OCCPR"},{"publicId":"7203746","version":"1","longName":"Screening and Eligibility","context":"OCCPR"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"DCP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"OCCPR","type":"USED_BY","context":"OCCPR"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Does the participant satisfy","type":"Preferred Question Text","description":"Does the participant satisfy all of the eligibility criteria?","url":null,"context":"DCP"},{"name":"DCP Document Text 2","type":"Alternate Question Text","description":"Eligibility","url":null,"context":"DCP"},{"name":"DCP Document Text 3","type":"Alternate Question Text","description":"Does the participant satisfy all of the eligibility criteria to begin Run-In Phase?","url":null,"context":"DCP"},{"name":"DESK Document Text","type":"Alternate Question Text","description":"Eligibility Status","url":null,"context":"DCP"},{"name":"DCP Document Text 4","type":"Alternate Question Text","description":"Does the participant satisfy all of the pre-registration eligibility criteria?","url":null,"context":"DCP"},{"name":"CTEP CRF Text 1","type":"Alternate Question Text","description":"Does the patient satisfy all of the eligibility criteria specified in the protocol for the Advanced Disease Cohort?","url":null,"context":"CTEP"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Does the patient satisfy all of the hepatitis B and/or Hepatitis C criteria specified in the protocol?","url":null,"context":"NRG"},{"name":"CPTAC-Elig-1","type":"Alternate Question Text","description":"Does the Candidate meet all eligibility criteria defined within the Study Protocol for a new primary, metastatic or recurrent malignant neoplasm?","url":null,"context":"OCCPR"},{"name":"Practice Site Eligibility criteria met","type":"Alternate Question Text","description":"Does the Practice Site meet all the eligibility criteria as outlined in the protocol for participation in the study?","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Is the parent eligible?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DF04A62-AB48-1BC3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-03-01","modifiedBy":"PONCEO","dateModified":"2021-09-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}